Overview of main takeaways/clinical or research on three articles:
- Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
- The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
- Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences and Current Use in Australian Patients
Facebook Comments